These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2353668)

  • 1. Short- and long-term mechanisms of sudden cardiac death in congestive heart failure.
    Helfant RH
    Am J Cardiol; 1990 Jun; 65(23):41K-43K. PubMed ID: 2353668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations of aldosterone in congestive heart failure, arrhythmias and sudden cardiac death. Editorial overview.
    Castaigne A
    Am J Cardiol; 1990 Jun; 65(23):39K-40K. PubMed ID: 2353667
    [No Abstract]   [Full Text] [Related]  

  • 3. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure. Basis of a new physiologic approach to control of arrhythmia.
    Packer M; Gottlieb SS; Kessler PD
    Am J Med; 1986 Apr; 80(4A):23-9. PubMed ID: 2871753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate and long-term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure.
    Packer M; Gottlieb SS; Blum MA
    Am J Med; 1987 Mar; 82(3A):4-10. PubMed ID: 2882674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of spironolactone on serum and muscle electrolytes in patients on long-term diuretic therapy for congestive heart failure and/or arterial hypertension.
    Dyckner T; Wester PO; Widman L
    Eur J Clin Pharmacol; 1986; 30(5):535-40. PubMed ID: 3758141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure and electrolyte disturbances.
    Schwinger RH; Erdmann E
    Methods Find Exp Clin Pharmacol; 1992 May; 14(4):315-25. PubMed ID: 1507935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of spironolactone on ventricular arrhythmias in congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.
    Ramires FJ; Mansur A; Coelho O; Maranhão M; Gruppi CJ; Mady C; Ramires JA
    Am J Cardiol; 2000 May; 85(10):1207-11. PubMed ID: 10802002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease.
    Barr CS; Lang CC; Hanson J; Arnott M; Kennedy N; Struthers AD
    Am J Cardiol; 1995 Dec; 76(17):1259-65. PubMed ID: 7503007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart failure and rhythm disorders].
    Mukharliamov NM
    Ter Arkh; 1987; 59(9):4-8. PubMed ID: 3424186
    [No Abstract]   [Full Text] [Related]  

  • 11. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure.
    Gao X; Peng L; Adhikari CM; Lin J; Zuo Z
    J Card Fail; 2007 Apr; 13(3):170-7. PubMed ID: 17448413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in congestive heart failure therapy.
    Nicklas JM
    Hosp Pract (Off Ed); 1990 Jan; 25 Suppl 1():22-9; discussion 30-1. PubMed ID: 2104875
    [No Abstract]   [Full Text] [Related]  

  • 13. Potassium-sparing diuretics.
    Dyckner T; Wester PO
    Acta Med Scand Suppl; 1986; 707():79-83. PubMed ID: 3461689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spironolactone in the management of congestive heart failure.
    Muller JE
    Am J Cardiol; 1990 Jun; 65(23):51K-53K. PubMed ID: 2353671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congestive heart failure and ventricular arrhythmias.
    Nestico PF; Morganroth J
    Cardiovasc Clin; 1988; 19(1):253-62. PubMed ID: 3048683
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B; Cybulski J; Chamiec T
    Pol Merkur Lekarski; 2000 Aug; 9(50):519-21. PubMed ID: 11081314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone and antialdosterone therapy in congestive heart failure.
    Weber KT; Villarreal D
    Am J Cardiol; 1993 Jan; 71(3):3A-11A. PubMed ID: 8422002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationship of magnesium and congestive heart failure.
    Seelig MS
    Wien Med Wochenschr; 2000; 150(15-16):335-41. PubMed ID: 11105329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure.
    Shah NC; Pringle SD; Donnan PT; Struthers AD
    J Hypertens; 2007 Nov; 25(11):2345-51. PubMed ID: 17921831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic action of pharmacological administration of magnesium in heart failure: a critical review of new data.
    Sueta CA; Patterson JH; Adams KF
    Magnes Res; 1995 Dec; 8(4):389-401. PubMed ID: 8861138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.